- Home
- WIMI vs ABOS Comparison
WIMI vs ABOS Comparison
Compare WIMI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- ABOS
- Stock Information
- Founded
- WIMI 2015
- ABOS 1996
- Country
- WIMI China
- ABOS United States
- Employees
- WIMI N/A
- ABOS N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- ABOS Health Care
- Exchange
- WIMI Nasdaq
- ABOS Nasdaq
- Market Cap
- WIMI 94.3M
- ABOS 76.9M
- IPO Year
- WIMI 2020
- ABOS 2021
- Fundamental
- Price
- WIMI $0.77
- ABOS $1.08
- Analyst Decision
- WIMI
- ABOS Strong Buy
- Analyst Count
- WIMI 0
- ABOS 3
- Target Price
- WIMI N/A
- ABOS $7.33
- AVG Volume (30 Days)
- WIMI 6.3M
- ABOS 206.3K
- Earning Date
- WIMI 01-01-0001
- ABOS 03-27-2025
- Dividend Yield
- WIMI N/A
- ABOS N/A
- EPS Growth
- WIMI N/A
- ABOS N/A
- EPS
- WIMI N/A
- ABOS N/A
- Revenue
- WIMI $84,137,968.00
- ABOS N/A
- Revenue This Year
- WIMI N/A
- ABOS N/A
- Revenue Next Year
- WIMI N/A
- ABOS N/A
- P/E Ratio
- WIMI N/A
- ABOS N/A
- Revenue Growth
- WIMI 19.25
- ABOS N/A
- 52 Week Low
- WIMI $0.63
- ABOS $1.05
- 52 Week High
- WIMI $2.92
- ABOS $4.06
- Technical
- Relative Strength Index (RSI)
- WIMI 46.58
- ABOS 34.99
- Support Level
- WIMI $0.74
- ABOS $1.14
- Resistance Level
- WIMI $1.17
- ABOS $1.28
- Average True Range (ATR)
- WIMI 0.13
- ABOS 0.10
- MACD
- WIMI 0.02
- ABOS -0.01
- Stochastic Oscillator
- WIMI 19.04
- ABOS 6.98
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings primarily consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.